Abstract Human uterine fibroblasts (HuF) isolated from the maternal part (decidua parietalis) of a term placenta provide a useful model of in vitro cell differentiation into decidual cells (decidualization, a critical process for successful pregnancy). After isolation, the cells adhere to plastic and have either a small round or spindle-shaped morphology that later changes into a flattened pattern in culture. HuF robustly proliferate in culture until passage 20 and form colonies when plated at low densities. The cells express the mesenchymal cell markers fibronectin, integrin-β1, ICAM-1 (CD54), and collagen I. Flow cytometry of HuF has detected the presence of CD34, a marker of the hematopoietic stem cell lineage, and an absence of CD10, CD11b/Mac, CD14, CD45, and HLA type II. Furthermore, they also express the pluripotency markers SSEA-1, SSEA-4, Oct-4, Stro-1, and TRA-1-81 as detected by confocal microscopy. Treatment for 14-21 days with differentiation-inducing media leads to the differentiation of HuF into osteoblasts, adipocytes, and chondrocytes. The presence of α-smooth muscle actin, calponin, and myosin light-chain kinase in cultured HuF implies their similarity to myofibroblasts. Treatment of the HuF with dimethyl sufoxide causes reversion to the spindleshaped morphology and a loss of myofibroblast characteristics, suggesting a switch into a less differentiated phenotype.
Introduction
The human term placenta has been recently described as an attractive source of pluripotent "adult stem cells" (In't Anker et al. 2004; Zhang et al. 2004; Yen et al. 2005; Li et al. 2005; Portmann-Lanz et al. 2006; Battula et al. 2007) . Mesenchymal stem cells (MSC) isolated from the placenta have similar characteristics to widely used bone marrowderived MSC. Moreover, maternal MSC from term deciduae show a significantly higher expansion capacity than MSCs from adult bone marrow (In't Anker et al. 2004 ). Finally, their isolation from discarded placentas is noninvasive, abundant, and ethically unbiased.
Fibroblasts isolated from the maternal part (decidua parietalis) of the term placenta represent a proliferating population of non-differentiated cells, which are maintained in the decidualized uterine endometrium (Markoff et al. 1983; Richards et al. 1995) . These cells have been used by various investigators (Markoff et al. 1983; Richards et al. 1995; Brar et al. 2001; Eyal et al. 2007; Kessler et al. 2006) , including ourselves (Strakova et al. 2000; Ihnatovych et al. 2007) , as a useful model of in vitro cell differentiation into decidual cells (decidualization). This process of differentiation is critical for successful implantation and pregnancy.
We have termed these cells human uterine fibroblasts (HuF); they are also referred to by other investigators as decidual stromal cells.
HuF been shown to express antigens associated with hematopoietic cells (Montes et al. 1996) , although they have been suggested to be more closely related to bone marrow stromal precursors (García-Pacheco et al. 2001) . Their morphology and phenotype are described as being similar to those of myofibroblasts (Oliver et al. 1999; Kimatrai et al. 2003) , α-smooth muscle actin (α-SMA) expressing fibroblastic cells with contractile activity that are involved in wound retraction.
The purpose of our study has been to characterize the presence of pluripotency markers in HuF further and to evaluate the ability of HuF to differentiate into mesodermal lineages.
Materials and methods

Materials
The ES Cell Marker Sample kit (cat. no. SCR002) containing antibodies for the detection of stage-specific embryonic markers (SSEA-1 and SSEA-4), tumor recognition antigens (TRA-1-60 and TRA-1-81), and Oct-4, the Mesenchymal Stem Cell Characterization kit (cat. no. SCR018) for detection of integrin β1, CD54, collagen type I, fibronectin, and CD14, and antibodies against Stro-1 (mouse monoclonal MAB4315) were from Chemicon (Millipore, Billerica, Mass.). Mouse monoclonal anti-human α-SMA antibody clone 1A4 was from DAKO (Glastrup, Denmark). Antibodies against CD11b/Mac-1 (mouse monoclonal, cat. no. 555386), CD34 (mouse monoclonal, cat. no. 555820), CD45 (mouse monoclonal, cat. no. 555480), CD10 (mouse monoclonal, cat. no. 555373), and major histocompatibility class II HLA-DR, DP, and DQ antigens (mouse monoclonal, cat. no. 555557) were from BD Pharmingen (San Diego, Calif.). Monoclonal β-actin antibody clone AC 15 was purchased from Sigma (St. Louis, Mo.). Rabbit polyclonal antibody to myosin light-chain kinase (MLCK) was kindly provided by Dr. De Lanerolle (University of Illinois at Chicago, Chicago, Ill.), and its preparation and characterization was as described previously (De Lanerolle et al. 1981) . Vimentin antibody was from Zymed Laboratories (San Francisco, Calif.), and calponin antibody was from Santa Cruz Biotechnology (Santa Cruz, Calif.). Prolong Antifade mounting medium containing DAPI (4,6-diamidino-2-phenyl-indole) was purchased from Molecular Probes (Eugene, Ore.). All cell culture supplies were obtained from Invitrogen (Grand Island, N.Y.) . Other reagents of cell culture grade were purchased from Fisher Scientific (Itasca, Ill.) or Sigma. HuF were isolated from the decidua parietalis dissected from the placental membranes after normal vaginal delivery at term. Decidua parietalis tissue was scraped with a cell scraper from the chorion of placental membranes and digested in 0.5% collagenase and 0.02% DNase in calciumand magnesium-free Hanks' balanced salt solution (HBSS) for 30 min at 37°C in a water bath under agitation. The supernatant was recovered and placed at 4°C. The remaining tissue was further digested in 0.5% collagenase, 0.02% DNase, 0.1% hyaluronidase, and 0.1% pronase solution in HBSS for another 30 min. The cell suspensions from both digestions were centrifuged at 150g for 10 min, and the pellet was resuspended in HBSS. The suspensions were filtered through a series of nylon mesh filters (Small Parts, Miami Lakes, Fl.) of decreasing size, starting with 250 μm, followed by 70 μm, and then twice through 20 μm. The filtrates were centrifuged at 150g for 10 minutes. The pellet of isolated cells was resuspended in phenol red-free RPMI-1640 medium supplemented with 0.1 mM sodium pyruvate, 100 U/ml penicillin, 100 μg/ml streptomycin, and 10% fetal bovine serum depleted of steroids by treatment with dextran-coated charcoal (S-FBS). Cells were seeded on four culture plates (100 mm in diameter) and placed into an incubator at 37°C, 5% CO 2 . The following day, the plates were extensively washed with phosphate-buffered saline (PBS) to remove nonadherent cells (mainly decidual cells and red blood cells). At confluence, cells were trypsinized and used for experiments in passage numbers 3-5. The cell purity of confluent cells was assessed by immunocytochemistry with antibodies against cytokeratin (DAKO) and vimentin (Zymed Laboratories). Cells were negative for cytokeratin; fibroblast positivity, as estimated by vimentin staining, was greater than 97%. The cells proliferated robustly, and it was possible to freeze and grow them again after defrosting. Cells underwent senescence after approximately 20 passages.
Colony-forming assay
HuF cells in passages 3-4 were plated at various densities (4-10 cells/cm 2 or 500 cells/cm 2 ) in triplicate and allowed to grow in culture medium for 21 days. The culture medium was exchanged every 2-3 days, and the experiment was repeated three times. The cultures were stained with 1% (v/v) crystal violet (Sigma) in 10% ethanol for 5 min. The cells were washed twice with distilled water, and the number of colonies with a diameter larger than 2 mm was counted by using Quantity One 1-D analysis software on a ChemiDoc XRS System (Bio-Rad, Hercules, Calif.).
Flow cytometry
HuF cells (80%-90% confluent, passages 2-3) cultured in RPMI-1640 medium supplemented with 10% S-FBS, were used for analysis of cell-surface molecules. The cells were harvested and washed with PBS, and the cell suspension was adjusted to a concentration of 1.5×10 6 cells/ml to 2×10 6 cells/ml in ice-cold 3% bovine serum albumin (BSA)/PBS. HuF cells were incubated for 2 h at room temperature with mouse anti-human CD54, CD34, CD14, CD11b, CD10, CD45, HLA-DR, DP, and DQ monoclonal antibodies (1 μg antibody/10 6 cells). Antibodies with a matching isotype were used to detect nonspecific fluorescence. The cells were washed three times by centrifugation at 400g for 5 min and resuspending in ice-cold PBS. Fluorescein isothiocyanate (FITC)-conjugated secondary antibody diluted in 3% BSA/PBS was applied for 30 min in the dark. After incubation, HuF cells were washed three times with ice-cold PBS, resuspended in 0.2 ml 2% formalin, and analyzed for the aforementioned human antigens by using a Beckman-Coulter Elite ESP flow cytometer. Cytofluorimetric data were processed with WinMDI software (Joe Trotter, Scripps Research Institute, La Jolla, Calif.).
Immunofluorescence staining
HuF grown on glass coverslips were fixed with 4% paraformaldehyde, permeabilized with 0.1% Triton X-100, and then blocked with 5% BSA at room temperature. Incubations with primary antibodies against pluripotency markers (Oct-4, SSEA-1, SSEA-4, TRA-1-81, all used at a 1:10 dilution; Stro-1 used at 1:200), or mesenchymal cell markers (ICAM-1 used at 1:100), integrin β1 (1:500), collagen I (1:500), and fibronectin (1:1,500), or mouse IgG and rabbit IgG (at appropriate concentrations, negative controls) were carried out according to the manufacturer's recommendations, followed by incubation for 1 h with FITC-conjugated secondary antibodies (1:100). Coverslips were mounted with Prolong Antifade mounting medium containing DAPI. The images were captured by using a Zeiss LSM 510 laser confocal microscope (Carl Zeiss Microimaging, Thornwood, N.Y.).
Reverse transcription/polymerase chain reaction detection Cells were lysed with Trizol Reagent (Invitrogen, Carslbad, Calif.), and RNA was extracted according to the manufacturer's protocol. Reverse transcription (RT) was performed in a final volume of 20 μl with 2 μg total cellular RNA containing 200 U M-MLV reverse transcriptase (Invitrogen, Grand Island, N.Y.) . Polymerase chain reaction (PCR) primers specific for osteopontin (according to Zhang et al. 2004; 169-bp product) , fatty-acid-binding protein-4 (FABP-4; according to Larson et al. 2004; 387-bp product) , and collagen II (according to Zhang et al. 2004; 394-bp product) were used at a concentration of 50 pmol. The constitutively expressed histone H3.3 was used at a primer concentration of 10 pmol (primers according to Kim et al. 1998) . PCR products were created during 32 cycles consisting of 94°C for 1 min, then 60°C (or 55°C for osteopontin) for 2 min, and 72°C for 3 min, followed by a 15-min final extension at 72°C. The PCR products were then analyzed by electrophoresis in 2% agarose gels. Digital images were captured by Quantity One 1-D analysis software on a ChemiDoc XRS System (Bio-Rad).
Differentiation of cells into osteoblasts, adipocytes, and chondrocytes
HuF cells were plated in passages 3-4 at a density of 2.7×10 4 cells/cm 2 . After 4 days in culture (at confluency), the cells were subjected to differentiation treatments according to a variation of the original protocol of Pittenger et al. (1999) . The differentiation experiments were repeated at least three times each.
Osteogenic differentiation was achieved by incubating the cells in Dulbecco's modified Eagle's medium with high glucose (DMEM-HG) supplemented with 5% FBS (Premium Select, Atlanta Biologicals, Lawrenceville, Ga.), penicillin/streptomycin, sodium pyruvate, 50 nM dexamethasone, ascorbic acid (100 μg/ml), and 10 mM β-glycerol phosphate for 2-3 weeks. The medium was replaced every 2-3 days. Cells were lysed with Trizol Reagent (Invitrogen, Carslbad, Calif.) for RNA preparation or washed with PBS and fixed in 10% formalin. To assess mineralization, calcium deposits in cultures were stained with 2% Alizarin red S (Sigma) in PBS or by the von Kossa method. For von Kossa staining, the fixed plates were washed with distilled water and then treated with 1% AgNO 3 for 1 h, washed again with distilled water, and treated with 2.5% sodium thiosulfate for 5 min. The staining was examined under a light microscope.
Adipogenic differentiation was induced by incubating the cells in DMEM-HG supplemented with 5% heatinactivated FBS (Invitrogen), penicillin/streptomycin, sodium pyruvate, insulin, transferrin, selenious acid, BSA fraction V (ITS+1 supplement; Sigma), 1 μM dexamethasone, 0.5 mM isobutyl methylxanthine, 0.2 mM indomethacin for 7-14 days. The medium was replaced every 2-3 days. Cells were lysed with Trizol Reagent (Invitrogen) for RNA preparation or washed with PBS and fixed in 10% formalin. Cytoplasmic inclusions of neutral lipids were stained for 30 min with fresh Oil-red-O solution (stock: 0.5% in isopropanol, 3 parts stock mixed with 2 parts water, and filtered through a 0.2-μm filter). After the plates had been washed with water, the lipid vacuoles were identified as bright red inclusions within the cells.
For chondrogenic differentiation, cells were grown in a micromass pellet seeded into 15-ml conical tubes (0.25×10 6 cells/tube). The cultures were maintained in DMEM-HG supplemented with penicillin/streptomycin, sodium pyruvate, 2% heat-inactivated FBS, 10 ng/ml transforming growth factor-β3 (R&D Systems, Minneapolis, Minn.), ascorbic acid (50 μg/ml), ITS+1 supplement. The medium was replaced every 2-3 days, after low-speed centrifugation of the cells. After 14-21 days in culture, the chondrocyte pellet was fixed in 10% formalin and embedded in paraffin. The presence of extracellular matrix proteoglycans was visualized with Alcian blue staining.
Treatment of cells with dimethyl sufoxide
HuF cells were plated at a density of 1×10 5 cells/well in 6-well plates and allowed to grow until confluency. The medium was exchanged for RPMI 1640 with 10% heatinactivated FBS with penicillin/streptomycin and sodium pyruvate. Dimethyl sufoxide (DMSO) was added at a final concentration of 0.1%-2.5%. The medium was exchanged every 2 days, and the treatment with DMSO was repeated. On day 8 of treatment, the experiment was terminated, and the HuF were rinsed twice with PBS and lysed on ice with lysis buffer as previously described (Strakova et al. 2000) . The protein concentration was estimated by the Bradford assay (Bio-Rad Laboratories, Webster, Tex.). Equal amounts of total protein (2.5 μg) were separated by SDSpolyacrylamide gel electrophoresis and transferred onto polyvinylidene difluoride membranes. Following transfer, the blots were probed with specific antibodies against α-SMA (1:8,000), β-actin (1:8,000), MLCK (1:3,000), vimentin (1:10), and calponin (1:1,000). The immunoreactive bands were detected by enhanced chemiluminescence, and digital images were captured by Quantity One 1-D analysis software on a ChemiDoc XRS System (Bio-Rad).
Cell viability assay
Cells growing in 6-well plates were subjected to treatment with 2.5% DMSO for 8 days with regular exchanges of media every 2 days as described above. The attached cells (lifted by 0.4% trypsin treatment) and freely floating cells in cell supernatants were stained with 0.05% trypan blue. Live and dead cells from at least three wells in three independent experiments were counted by using a hemocytometer. Results are expressed as mean±SD. The difference between the controls and DMSO-treated cells was evaluated by statistical analysis by using SPSS12.0 (SPSS, Chicago, Ill). One-way analysis of variance was used to test the null hypothesis, followed by a two-tailed t-test for pairwise comparison.
Results
Characteristics of HuF
The method for the isolation of HuF cells from the decidua parietalis of a term placenta is simple (digestion followed by size filtration), and the cells can be cultured in common medium supplemented with S-FBS. HuF cells are extensively washed of any non-adherent cells 24 h after isolation. Adherent cells have heterogeneous shapes, most exhibiting a spindle-shaped morphology (some cells showing dendrites) with smaller amounts of highly reflective small, rounded, rapidly proliferating cells (Fig. 1a) . The cells later change, having a flattened pattern (Fig. 1b , day 5 of culture), and confluent cells form a monolayer (passage 3, Fig. 1c ). Cells are able to form colonies when plated at a low density (passage 3, Fig. 1d) . For plating at a density of 4-10 cells/cm 2 , the average ability to form colonies is approximately 35%. An increase in the plating density to 500 cells/cm 2 results in a decline in the ability to form colonies to approximately 10%. Flow cytometric analysis revealed strong positivity of cells for the mesenchymal cell marker CD54 (ICAM-1) and for CD34, an antigen detected on the precursors of the hematopoietic lineage. On the other hand, no positivity was observed for the common leukocyte antigen CD45, myelomonocytic antigen CD11b/Mac-1, monocyte and granulocyte marker CD14, neutral endopeptidase CD10, or major histocompatibility class II HLA-DR, DP and most DQ antigens (data not shown).
Presence of pluripotency markers Oct-4, Stro-1, SSEA-1, SSEA-4, and TRA-1-81 in HuF Confocal microscopy of fixed cells stained with antibodies against Oct-4, Stro-1, SSEA-1, SSEA-4, and keratinsulphate-associated antigen TRA-1-81 demonstrated the presence of these pluripotency markers in the cells (Fig. 2) . We did not detect staining for TRA-1-60.
Presence of mesenchymal cell markers
The presence of ICAM-1 demonstrated by flow cytometry was further confirmed by immunocytochemical staining (Fig. 3c) . In addition, HuF revealed strong positivity for collagen I (Fig. 3a) , integrin β1 (Fig. 3d) , and fibronectin (Fig. 3b) .
Osteogenic, adipogenic, and chondrogenic differentiation of HuF
HuF were tested for their ability to undergo differentiation into mesenchymal lineages. After treatment with osteogenicdifferentiation-inducing media for 14-21 days, HuF were able to differentiate into the osteocyte phenotype. Calcium deposits in fixed cells were detected by Alizarin red (Fig. 4a ) and von Kossa (Fig. 4b) staining. The cells cultured in osteogenic differentiation media expressed mRNA for the osteogenic marker, osteopontin, as detected by RT-PCR (Fig. 4c) .
The presence of lipid vacuoles in cells cultured in adipogenic medium for 7-14 days was detected by staining with Oil-red-O (Fig. 4e) . The mRNA for the adipocyte marker FABP-4 was detected by PCR in cells treated with adipogenic medium but was not present in the control cells (Fig. 4f ).
Chondrogenic differentiation was tested in cells grown in micromass. The cells in the culture medium without factors inducing chondrogenic differentiation were dispersed and unable to sustain a cohesive mass. In contrast, the cells with media inducing chondrogenesis adhered together, and the whole mass could be fixed in formalin and embedded in paraffin. The presence of proteoglycans was detected in the fixed cells by staining with Alcian blue (Fig. 4h) . The mRNA for the chondrogenic marker collagen II was detected in cells treated with chondrogenic medium (Fig. 4i) .
Regulation of HuF phenotype in the presence of DMSO
The cells grown in long-term culture exhibited a smoothmuscle-like morphology with prominent stress fibers. They spontaneously expressed α-SMA, the marker of smooth muscle cells. Treatment of such confluent cells with the polar solvent DMSO caused significant changes in overall cell morphology. The morphological changes in the cells, proportional to the DMSO dose (0.5%-2.5%), were noticeable as early as 24 h of DMSO treatment. Under DMSO treatment, the shape of HuF changed from the original flattened pattern (Fig. 5a ) to a more spindle-like or rounded shape (Fig. 5b-d) . The round cells, after being detached from the plates by stringent washing and replated, were able to attach, spread, form actin filaments, and proliferate (data not shown). However, the 2.5% DMSO treatment caused a significant decline in the ability of cells to further proliferate in comparison with the controls (data not shown), resulting in a decrease of live cells to about 1/5th of control levels (Fig. 5g ) on day 8 of treatment (compare live control "packed" cells in Fig. 5e with Fig. 5f ). Treatment of HuF with 2.5% DMSO (Fig. 5f ) for 8 days did not result in an increased amount of dead cells if estimated as a percentage of total cells (Fig. 5h ), in comparison with untreated HuF.
Changes in cytoskeletal protein expression related to cell morphology
Western blot analysis of cell lysate proteins (passages 3-4) after 8 days of treatment with DMSO (resulting in more spindle-like and rounded cells at lower cell density) demonstrated a dose-dependent decline in levels of α-SMA and the actin-binding protein calponin (Fig. 6a) . HuF cells are known to express short (130 kDa) and long (214 kDa) MLCK isoforms (Ihnatovych et al. 2007 ). Treatment with DMSO caused a decline in the short form of MLCK, whereas the levels of cytoplasmic β-actin and the intermediate filament protein vimentin remained unchanged (Fig. 6a) . The relationship of the round and spindle-like phenotype (as seen in the cells 24 h after isolation, passage 0; Fig. 1a ) with the lower content of α-SMA and calponin was confirmed by Western blot (Fig 6b) . No α-SMA was detectable in cell lysates from passage 0 cells, 24 h after plating. However, increased time in culture (5 days after isolation, passage 0) and the acquisition of a flattened phenotype (as illustrated in Fig. 1b ) resulted in increased levels of α-SMA, calponin, and MLCK, but unchanged levels of β-actin and vimentin (Fig. 6b) .
Discussion
The human placenta is an organ with a maternal and a fetal portion. In this paper, we describe novel properties of the cells isolated from the maternal part of the placental membrane: the decidua parietalis. Because of their ability to differentiate into decidual cells, these cells have been used for many years as a model system of in vitro decidualization (Markoff et al. 1983; Richards et al. 1995; Strakova et al. 2000; Brar et al. 2001; Kessler et al. 2006; Eyal et al. 2007; Ihnatovych et al. 2007) . They are easy to obtain from the human term placenta, have non-demanding culture requirements, and consistently show similar properties.
The cells contain mesenchymal cell markers (integrin β1, ICAM-1, collagen I, fibronectin, vimentin) much like those observed in mesenchymal cells from bone marrow (Conget and Minguell 1999; Seshi et al. 2000; Silva et al. 2003) . However, the flow cytometric analysis of HuF has detected positive antibody binding for CD34. The presence of this early hematopoietic marker has not been described in MSC isolated from fetal parts of the placenta (Zhang et al. 2004; Portmann-Lanz et al. 2006 ) but has been similarly observed in isolations from first-trimester human decidua parietalis (García-Pacheco et al. 2001) .
This is the first report of the expression of the stem/ progenitor cell markers SSEA-1, SSEA-4, Oct-4, Stro-1, and TRA-1-81 in cells isolated from the maternal part (decidua parietalis) of placental membranes. The presence of Oct-4, SSEA-4, and TRA-1-81 have been described on MSC derived from whole placenta (Yen et al. 2005; Battula et al. 2007) or from amniotic fluid (Delo et al. 2006; Kim et al. 2007 ). The presence of pluripotency markers and of hematopoietic and mesenchymal markers on HuF suggests that these cells are less differentiated than classical bonemarrow-derived MSC. The initial culture of HuF contains a majority of spindleshaped cells and a minority of small, round, rapidly proliferating cells, similar to the descriptions of cultures of MSC from bone marrow Colter et al. 2000 ). These small, rapidly self-renewing cells are apparently the earliest progenitors and the most rapidly replicating cells in cultures of MSCs .
The changes in cell morphology (from spindle-like to a flattened pattern) with increasing time in culture are connected to changes in the cytoskeleton. α-SMA is required for the initial formation of the cortical filament bundles in spreading rat lung myofibroblasts (Hinz et al. 2003) . In contrast to the ubiquitously expressed cytoplasmic γ and β non-muscle actins, α-SMA is a tissue-specific actin isoform (Khaitlina 2001) . During lung myofibroblast cell spreading, the rate of incorporation of α-SMA into actin filaments is much slower than the incorporation of β-actin (Khaitlina 2001 ). This agrees with our observation of no detectable α-SMA, MLCK, or calponin in the initial spindle-shaped and round cells after isolation, but the expression of these proteins increases as the cells spread into a flattened pattern and actin fibers appear. Of note, levels of the ubiquitously expressed β-actin or the intermediate filament protein vimentin are detectable in cells just after isolation.
The expression of α-SMA, which is apparent in HuF during long-term cell culture, is considered to be a phenotypic marker for myofibroblasts (Wang et al. 2006 ). The term "myofibroblast" was proposed many years ago for fibroblastic cells located within granulation tissue and exhibiting an important cytoplasmic microfilamentous apparatus (Gabbiani 2003) . Myofibroblasts are present in healing wounds, scars, and fibrocontractive lesions where they contribute to fibrosis (Wang et al. 2006 cells isolated from the placenta from which the placental membranes have been removed (Zhang et al. 2004) . We have demonstrated that, even with myofibroblast characteristics (presence of α-SMA and other markers of smoothmuscle cells), the HuF cells are able to differentiate further into mesenchymal lineages of osteoblasts, adipocytes, and chondrocytes, displaying their plasticity and multipotency. DMSO is an efficient solvent for water-insoluble compounds. It is frequently used in biological studies and in the cryopreservation of various cell types. DMSO was approved in the USA by the Federal Drug Administration in 1977 as an intravesical therapy for patients with interstitial cystitis, demonstrating a therapeutic benefit in approximately 50%-70% of cases (Moldwin et al. 2007 ). In spite of its clinical application, the mechanism of DMSO action is still poorly understood. Numerous cellular and molecular effects of DMSO have been reported, including its effect on cell differentiation (for a review, see Santos et al. 2003) . Depending on cell type, DMSO either induces or inhibits cell differentiation. In HuF cells, changes in cells induced by DMSO are connected with a loss of α-SMA, the short isoform of MLCK, and calponin, whereas β-actin and vimentin remain in uniform amounts. A similar transition to a less differentiated state after DMSO treatment has been described in myofibroblasts originating from bone-marrow-derived MSC, with mTOR being suggested as a participant in the transition regulation (Hegner et al. 2005) . Regulation of the phenotype of human MSCs has been suggested as being of relevance for novel therapeutic approaches in arterosclerosis and intimal hyperplasia after vascular injury (Hegner et al. 2005 ).
In conclusion, we suggest that myofibroblast-like HuF should provide an interesting cell model (see Fig. 7 ) to explore further their use as a possible tool for regenerative medicine. This is based upon their ready availability from the term placenta, their low maintenance requirements in cell culture, and their capacity to differentiate into decidual cells, osteoblasts, adipocytes, and chondrocytes.
